Sodium azulensulfonate - Sichuan Guokang Pharmaceutical
Latest Information Update: 03 May 2016
At a glance
- Originator Sichuan Guokang Pharmaceutical
- Class Anti-inflammatories; Organic chemicals; Skin disorder therapies
- Mechanism of Action Inflammation mediator modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Gastritis